Cargando…

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis

BACKGROUND: Double-blind, placebo-controlled trials (DBPCTs) have confirmed the efficacy of allergen-specific immunotherapy (AIT) with depigmented-polymerized allergen extracts (DPAEs). This systematic review evaluates the efficacy of AIT using different allergens in different severity stages of rhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mösges, Ralph, Valero Santiago, Antonio, Allekotte, Silke, Jahed, Nilufar, Astvatsatourov, Anatoli, Sager, Angelika, Sánchez-López, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549305/ https://www.ncbi.nlm.nih.gov/pubmed/31171962 http://dx.doi.org/10.1186/s13601-019-0268-5

Ejemplares similares

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023)

Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
por: Pfaar, Oliver, et al.
Publicado: (2015)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022)

2 Dose Optimizing Study of a Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test
por: Sager, Angelika, et al.
Publicado: (2012)

Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy
por: Köther, Janina, et al.
Publicado: (2018)

1 Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts is Effective and Safe in Patients With Severe SAR Highly Sensitized against Pollen Allergens
por: Gruber, Michaela, et al.
Publicado: (2012)

10 Seasonal Versus Symptom-based Evaluation of a Depigmented Grass-Birch Allergoid
por: Pfaar, Oliver, et al.
Publicado: (2012)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis
por: Palathumpattu, Binoy, et al.
Publicado: (2022)

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
por: Sager, Angelika, et al.
Publicado: (2012)

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season
por: Mösges, Ralph, et al.
Publicado: (2019)

Depigmenting Effect of Catechins
por: Sato, Kazuomi, et al.
Publicado: (2009)

Hemorrhage rate after coblation tonsillectomy: a meta-analysis of published trials
por: Mösges, Ralph, et al.
Publicado: (2011)

Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016)

Depigmented patches in a child
por: Leszczynska, Maria, et al.
Publicado: (2021)

Depigmenting potential of lichen extracts evaluated by in vitro and in vivo tests
por: Malaspina, Paola, et al.
Publicado: (2020)

Allergen immunotherapy phase II trials: Challenges in dose finding
por: Kleine-Tebbe, J., et al.
Publicado: (2019)

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020)

Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
por: Kim, Laura, et al.
Publicado: (2014)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2019)

In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy
por: Morales, María, et al.
Publicado: (2017)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
por: Pfaar, Oliver, et al.
Publicado: (2023)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
por: Nahm, Dong-Ho, et al.
Publicado: (2016)

Safety and adverse reactions in subcutaneous allergen immunotherapy: a review
por: Incorvaia, Cristoforo, et al.
Publicado: (2023)

Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG
por: van den Boorn, Jasper G., et al.
Publicado: (2010)

Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center
por: Lemberg, Marie-Luise, et al.
Publicado: (2017)

Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018)

Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011)

Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement
por: Taher, Yousef A., et al.
Publicado: (2010)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Kaempferol and Kaempferol Rhamnosides with Depigmenting and Anti-Inflammatory Properties
por: Rho, Ho Sik, et al.
Publicado: (2011)

Depigmented Verruca with Halo in a Case of Generalized Vitiligo
por: Muralitharan, Amrithaa, et al.
Publicado: (2023)

Allergen-Specific IgE and IgG4 as Biomarkers for Immunologic Changes during Subcutaneous Allergen Immunotherapy
por: Nikolov, Georgi, et al.
Publicado: (2021)

Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
por: Prnjavorac, Besim, et al.
Publicado: (2014)

Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study
por: Tat, Tugba S.
Publicado: (2018)

Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling
por: Aue, Adam, et al.
Publicado: (2021)

Comparison of weight per volume and protein nitrogen units in non-standardized allergen extracts: implications for prescribing subcutaneous immunotherapy
por: Dua, Benny, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s6aph3tbfndfmvt2ag4cf2u9g